Vaccine News and Research

Latest Vaccine News and Research

Stem cells derived from bone marrow provide better quality of life to transplant patients

A large, nationwide study published in the journal JAMA Oncology found that people who received transplants of cells collected from a donor's bone marrow the original source for blood stem cell transplants, developed decades ago had better self-reported psychological well-being, experienced fewer symptoms of a common post-transplant side effect called graft-vs.-host disease and were more likely to be back at work five years after transplantation than those whose transplanted cells were taken from the donor's bloodstream.

17 Aug 2016

NIH funds collaborative project to develop better vaccine adjuvants for many diseases

Dr. Qizhi Cathy Yao, professor of surgery, molecular virology and microbiology, and pathology & immunology at Baylor College of Medicine, has been awarded a National Institutes of Health grant to fund a collaborative project with Molecular Express, Inc.

12 Aug 2016

Nigerian Government reports 2 children paralyzed by wild poliovirus

After more than two years without wild poliovirus in Nigeria, the Government reported today that 2 children have been paralyzed by the disease in the northern Borno state.

12 Aug 2016

RNA silencing technique developed by spinoff from UM-Madison effective in battling hepatitis B

A method for "silencing" RNA that emerged from a University of Wisconsin-Madison spinoff company is in clinical trials in Europe, Asia and the United States against hepatitis B, an infection that can destroy the liver.

11 Aug 2016

Distraction techniques can help calm children from shot-related anxiety during flu season

A typical visit to the pediatrician when it is time for a child to get a shot can include tears, tantrums and might not seem worth the trouble.

10 Aug 2016

Industrial chemicals exceed safety levels in public drinking water supplies for 6 million Americans

Levels of a widely used class of industrial chemicals linked with cancer and other health problems--polyfluoroalkyl and perfluoroalkyl substances (PFASs)--exceed federally recommended safety levels in public drinking water supplies for six million people in the U.S., according to a new study led by researchers from Harvard T.H. Chan School of Public Health and the Harvard John A. Paulson School of Engineering and Applied Sciences.

10 Aug 2016

Wistar scientists discover novel mechanism that helps tumors adapt to hypoxia

One of the many reasons tumors are so difficult to treat is that they are able to adapt whenever they are exposed to unfavorable conditions.

9 Aug 2016

Scientists modeling new control mechanism to combat Zika-infecting mosquitoes

The images are heartbreaking: thousands of infants born with small, misshapen heads, the result of a rare neurological disorder, called microcephaly, which can cause a myriad of intellectual and developmental disabilities. The culprit? Zika, a mosquito-borne virus that has swept through many parts of South America and more recently surfaced in Florida.

8 Aug 2016

Mayo Clinic expert offers tips to avoid illness at major events

Zika isn't the only health concern now that the games have begun in Rio. Massive crowds from around the globe will be at the Olympics, and that means a world-class array of germs will mix with them.

8 Aug 2016

GSK launches educational campaign to help raise awareness of meningitis

GSK today launched an educational campaign to help raise awareness of meningitis, a rare but potentially deadly disease.

8 Aug 2016

UM SOM selected as study site for human safety trial of new Zika vaccine

As world leaders increasingly recognize the Zika virus as an international public health threat, the Center for Vaccine Development at the University of Maryland School of Medicine's Institute for Global Health has been chosen as one of three study sites in a human safety trial of a new Zika vaccine.

7 Aug 2016

Wistar scientists discover marker for PMN-MDSCs in the blood of cancer patients

Myeloid-derived suppressor cells (MDSCs) are a population of immune cells that have been implicated in tumor resistance to various types of cancer treatment, including targeted therapies, chemotherapy and immunotherapy.

5 Aug 2016

Three vaccine candidates provide complete protection against Zika virus in rhesus monkeys

A month after announcing that two promising vaccine candidates provided mice with complete protection against the Zika virus, a research team at Beth Israel Deaconess Medical Center, in collaboration with scientists at Walter Reed Army Institute of Research and the University of São Paulo, now reports achieving complete protection against Zika virus in rhesus monkeys.

5 Aug 2016

Genome-wide study sheds light on evolution of pollen allergens

A joint University of Adelaide-Shanghai Jiao Tong University study has provided the first broad picture of the evolution and possible functions in the plant of pollen allergens.

5 Aug 2016

Researchers report promising vaccine strategy for immunizing against herpes viruses

Oral and genital herpes are caused by the herpes simplex virus type 1 (HSV-1) and the herpes simplex virus type 2 (HSV-2), which both cause lifelong infection. HSV-2 infection is associated with increased risk for HIV infection.

4 Aug 2016

NIH launches clinical trial of experimental vaccine candidate for preventing Zika virus infection

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has launched a clinical trial of a vaccine candidate intended to prevent Zika virus infection.

3 Aug 2016

PD-1-responsive T cells may offer clues to design more effective drugs for cancer

Cancer immunotherapy drugs that block the inhibitory PD-1 pathway have shown success in clinical trials and are now FDA-approved for melanoma, lung cancer and bladder cancer. Yet many patients' tumors do not respond to these drugs.

3 Aug 2016

Griffith University to collaborate with Olymvax for new vaccine technology that could benefit millions

Griffith University will partner with a Chinese pharmaceutical, Olymvax Biopharmaceuticals Inc. for a new vaccine that could benefit millions.

2 Aug 2016

Vaccines unsuccessful in protecting obese mice against influenza infections, study finds

A study led by St. Jude Children's Research Hospital found that obese mice are not protected against influenza infections by vaccines that include adjuvants, raising concerns about vaccine effectiveness in obese humans who are known to be at an increased risk for severe flu. The findings appear today in the scientific journal mBio.

2 Aug 2016

Researchers shed light on mechanism for inducing memory B cell differentiation

A group of researchers at Immunology Frontier Research Center (IFReC), Osaka University and RIKEN Center for Integrative Medical Sciences jointly clarified the mechanism for inducing germinal-center B cells' differentiation into memory B cells, immune cells that remember antigens, at the molecular level.

2 Aug 2016

Vaccine News and Research

Latest Vaccine News and Research

Stem cells derived from bone marrow provide better quality of life to transplant patients

NIH funds collaborative project to develop better vaccine adjuvants for many diseases

Nigerian Government reports 2 children paralyzed by wild poliovirus

RNA silencing technique developed by spinoff from UM-Madison effective in battling hepatitis B

Distraction techniques can help calm children from shot-related anxiety during flu season

Industrial chemicals exceed safety levels in public drinking water supplies for 6 million Americans

Wistar scientists discover novel mechanism that helps tumors adapt to hypoxia

Scientists modeling new control mechanism to combat Zika-infecting mosquitoes

Mayo Clinic expert offers tips to avoid illness at major events

GSK launches educational campaign to help raise awareness of meningitis

UM SOM selected as study site for human safety trial of new Zika vaccine

Wistar scientists discover marker for PMN-MDSCs in the blood of cancer patients

Three vaccine candidates provide complete protection against Zika virus in rhesus monkeys

Genome-wide study sheds light on evolution of pollen allergens

Researchers report promising vaccine strategy for immunizing against herpes viruses

NIH launches clinical trial of experimental vaccine candidate for preventing Zika virus infection

PD-1-responsive T cells may offer clues to design more effective drugs for cancer

Griffith University to collaborate with Olymvax for new vaccine technology that could benefit millions

Vaccines unsuccessful in protecting obese mice against influenza infections, study finds

Researchers shed light on mechanism for inducing memory B cell differentiation

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in